5 Results

People

  1. Noy
    Noy
  2. Wegner
    Wegner
  3. Palomba
    Palomba
  4. Zelenetz
    Zelenetz
  5. Gerecitano
    Gerecitano
  6. Hamlin
    Hamlin
  7. Moskowitz
    Moskowitz
  8. Portlock
    Portlock
  9. Straus
    Straus
  10. Drullinsky
    Drullinsky

Groups

  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Lymphoma (5)
  5. Breast Medicine Service (2)
  6. Molecular Imaging and Therapy Service (2)
  7. Radiology, Department of (2)
  8. Solid Tumor Oncology Division (2)
  9. Survivorship Research (2)
  10. Biostatistics Service (1)
  1. "Paul Hamlin"
  2. "Brett Wegner"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Lymphoma (5)
  5. Breast Medicine Service (2)
  6. Molecular Imaging and Therapy Service (2)

More Groups

People
  1. Ariela Noy (5)
  2. Brett Wegner (5)
  3. David Straus (5)
  4. Paul Hamlin (5)
  5. Andrew Zelenetz (4)
  6. Maria Palomba (4)

More People

Years
  1. 2015 (1)
  2. 2012 (1)
  3. 2010 (1)
  4. 2008 (1)
  5. 2005 (1)
Publications
  1. Blood (2)
  2. Annals of Oncology (1)
  3. British Journal of Haematology (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Hematology (2)
  2. American Society of Clinical Oncology (1)
  3. John Wiley & Sons (1)
  4. Oxford University Press (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
    Journal Article

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Lia Palomba, M.; Drullinsky, P. R.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Elstrom, R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Final results of a phase II study of sequential R-CHOP and yttrium-90 ibritumomab tiuxetan (RIT) for elderly high risk patients with untreated diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Hamlin, P. A. Jr; Rodriguez, M. A.; Noy, A.; Portlock, C. S.; Straus, D.; McLaughlin, P.; Pro, B.; Fayad, L.; Hagemeister, F.; Wegner, B.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Sequential RCHOP and yttrium-90 ibritumomab tiuxetan (RIT) is a highly effective regimen for high risk elderly patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B.; Noy, A.; Gerecitano, J.; Palomba, M. L.; Portlock, C.; Straus, D.; Pro, B.; Fayad, L.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save